NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 3443.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 10-Jul-2014
Virology
Bacterial colonization prior to catching the flu may protect against severe illness
Severe illness and even death are likely to result if you develop another respiratory infection after catching the flu. Now, however, a team of Wistar researchers has determined that if you reverse the order of infection, pneumococcus bacteria may actually protect against a bad case of the flu. The bacterial protein pneumolysin, a bacterial virulence factor, might protect certain immune system cells (macrophages) in the alveoli of the lungs, preventing inflammation and, thus, pneumonia.
National Institutes of Health, BD Biosciences

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute

Public Release: 10-Jul-2014
Neuron
Working to loosen the grip of severe mental illness
In newly published research in the journal Neuron, Michael Cole of Rutgers has determined that the underlying brain architecture of a person at rest is basically the same as that of a person performing a variety of tasks. This is important to the study of mental illness, says Cole, because it is easier to analyze a brain at rest.
NIH/National Institute of Mental Health

Contact: Rob Forman
robert.forman@rutgers.edu
973-972-7276
Rutgers University

Public Release: 10-Jul-2014
PLOS Neglected Tropical Diseases
Control strategy for Dengue, malaria increases risk of West Nile virus
Mosquitoes infected with the bacteria Wolbachia are more likely to become infected with West Nile virus and more likely to transmit the virus to humans, according to a team of researchers.
National Institutes of Health

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State

Public Release: 10-Jul-2014
Molecular Therapy
Patient-specific stem cells and personalized gene therapy
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss. The approach, the first of its kind, takes advantage of induced pluripotent stem cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.
National Institutes of Health

Contact: Lucky Tran
lt2549@cumc.columbia.edu
212-305-3689
Columbia University Medical Center

Public Release: 10-Jul-2014
International Journal of Clinical and Experimental Hypnosis
Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about
Men who experience hot flashes are unlikely to talk much about it, but they may find relief from their silent suffering if they are willing to try an unusual treatment, according to findings from a Baylor University case study.
National Institutes of Health

Contact: Terry Goodrich
terry_goodrich@baylor.edu
254-710-3321
Baylor University

Public Release: 10-Jul-2014
Environmental Health Perspectives
Climate change may bring more kidney stones
As daily temperatures increase, so does the number of patients seeking treatment for kidney stones. In a study that may both reflect and foretell a warming planet's impact on human health, a research team found a link between hot days and kidney stones in 60,000 patients in several US cities with varying climates.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Ashley Moore
MOOREA1@email.chop.edu
267-426-6071
Children's Hospital of Philadelphia

Public Release: 10-Jul-2014
Current Biology
Chimpanzee intelligence determined by genes
A chimpanzee's intelligence is largely determined by its genes, while environmental factors may be less important than scientists previously thought, according to a Georgia State University research study.
National Institutes of Health, NIH/National Center for Research Resources

Contact: LaTina Emerson
lemerson1@gsu.edu
404-413-1353
Georgia State University

Public Release: 10-Jul-2014
Cell
New compound treats both blindness and diabetes in animal studies
In a new study led by UC San Francisco scientists, a chemical compound designed to precisely target part of a crucial cellular quality-control network provided significant protection, in rats and mice, against degenerative forms of blindness and diabetes.
Harrington Discovery Institute, National Institutes of Health, Juvenile Diabetes Research Foundation, and others

Contact: Peter Farley
peter.farley@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 10-Jul-2014
Stroke: Journal of the American Heart Association
High stress, hostility, depression linked with increased stroke risk
Higher levels of stress, hostility and depressive symptoms are associated with significantly increased risk of stroke or transient ischemic attack in middle-age and older adults. Significant increased risk was not observed for anger.
NIH/National Heart, Lung, and Blood Institute

Contact: Bridgette McNeill
Bridgette.McNeill@heart.org
214-706-1135
American Heart Association

Public Release: 10-Jul-2014
Science
Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells
A study in the July 11 issue of Science finds that circulating tumor cells captured with a microchip-based device developed at Massachusetts General Hospital can be cultured to establish cell lines for genetic analysis and drug testing and that those cell lines accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs.
Johnson & Johnson, Stand Up to Cancer, Breast Cancer Research Foundation, National Institutes of Health, Howard Hughes Medical Institute

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Public Release: 10-Jul-2014
Science
Study points to potential new target for antibiotics against E. coli, other bugs
Scientists have identified a protein that is essential to the survival of E. coli bacteria, and consider the protein a potential new target for antibiotics.
American Heart Association, National Institutes of Health

Contact: Natividad Ruiz
Ruiz.82@osu.edu
614-292-3426
Ohio State University

Public Release: 10-Jul-2014
Science
Window of opportunity against HIV comes from 'fitness bottleneck'
New research on HIV transmission among heterosexual couples in Zambia shows that viral fitness is an important basis of a 'genetic bottleneck' imposed every time a new person is infected. The findings define a window of opportunity for drugs or vaccines to prevent or limit infection.
NIH/National Institute of Allergy and Infectious Diseases, US Agency for International Development, International AIDS Vaccine Initiative

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 9-Jul-2014
Penn mesothelioma program receives $8 million NCI grant
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy in patients with malignant pleural mesothelioma.
NIH/National Cancer Institute

Contact: Lee-Ann Donegan
leeann.donegan@uphs.upenn.edu
215-349-5660
University of Pennsylvania School of Medicine

Public Release: 9-Jul-2014
Journal of Clinical Oncology
Vasectomy may increase risk of aggressive prostate cancer
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health.
NIH/National Cancer Institute

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard School of Public Health

Public Release: 9-Jul-2014
Nature
Protein pushes breast cancer cells to metastasize
Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists at Rockefeller University have identified a protein that makes breast cancer cells more likely to metastasize. What's more, the protein appears to trigger cancer's spread in part by blocking two other proteins that are normally linked to neurodegeneration, a finding that suggests these two disease processes could have unexpected ties.
National Institutes of Health, US Department of Defense

Contact: Franklin Hoke
fhoke@rockefeller.edu
212-327-8998
Rockefeller University

Public Release: 9-Jul-2014
Journal of Experimental Medicine
Bacteria hijack plentiful iron supply source to flourish
In an era of increasing concern about antibiotic-resistant illness, Case Western Reserve researchers have identified a new pathway to disabling disease: blocking bacteria's access to iron. The scientists showed how bacterial siderophore, a small molecule, captures iron from two supply sources to fan bacterial growth -- as well as how the body launches a chemical counterassault against this infection process. Their findings appear in a recent edition of The Journal of Experimental Medicine.
National Institutes of Health

Contact: Jeannette Spalding
jeannette.spalding@case.edu
216-368-3004
Case Western Reserve University

Public Release: 9-Jul-2014
Shock
Immune function predicts infection risk among child trauma patients
Researchers studying critically ill children with traumatic injuries have identified an immune marker that predicts which patients are likely to develop a hospital-acquired infection. The study is part of several larger efforts that could lead to the clinical implementation of quick-turnaround immune function tests and treatments to prevent or reverse immune system damage following critical illness or injury in pediatric patients.
National Institutes of Health, The Research Institute at Nationwide Children's Hospital

Contact: Gina Bericchia
MediaRelations@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital

Public Release: 9-Jul-2014
Nature Communications
Postcards from the photosynthetic edge
Using the world's most powerful x-ray laser, an international collaboration led by Berkeley Lab researchers took femtosecond 'snapshots' of water oxidation in photosystem II, the only known biological system able to harness sunlight for splitting the water molecule. The results should help advance the development of artificial photosynthesis for clean, green and renewable energy.
Department of Energy Office of Science, National Institutes of Health

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory

Public Release: 9-Jul-2014
Journal of Experimental Medicine
USC scientists discover immune system component that resists sepsis in mice
Molecular microbiologists from the Keck School of Medicine of the University of Southern California have discovered that mice lacking a specific component of the immune system are completely resistant to sepsis, a potentially fatal complication of infection.
National Institutes of Health, GRL, Hastings Foundation, Fletcher Jones Foundation

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences

Public Release: 9-Jul-2014
Nature
Lung cancer study hints at new treatments
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors. The new knowledge may expand treatments for patients because drugs targeting some of these genetic changes already are available or are in clinical trials.
National Institutes of Health

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Public Release: 9-Jul-2014
PLOS ONE
Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment
Over the last 60 years, the US Food and Drug Administration approved 20 medications for attention deficit/hyperactivity disorder based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval process.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Contact: Keri Stedman
keri.stedman@childrens.harvard.edu
617-919-3110
Boston Children's Hospital

Public Release: 9-Jul-2014
New England Journal of Medicine
Letrozole may help women with PCOS become pregnant
The drug letrozole results in higher birth rates in women with polycystic ovary syndrome, PCOS, than the current preferred infertility treatment drug, according to a nationwide study led by Penn State College of Medicine researchers.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH/National Center for Advancing Translational Sciences

Contact: Matt Solovey
msolovey@hmc.psu.edu
717-531-8606
Penn State

Public Release: 9-Jul-2014
Journal of the American Heart Association
Young Hispanics often obese, at higher risk for heart diseases
Obesity is common among US Hispanics and is severe among young Hispanics. This is associated with a considerable risk for heart diseases.
NIH/National Heart, Lung, and Blood Institute

Contact: Carrie Thacker
carrie.thacker@heart.org
214-706-1665
American Heart Association

Public Release: 9-Jul-2014
Nature
Human cells' protein factory has an alternate operating manual
Working with a gene involved in HIV infection, University of Maryland researchers discovered some human genes have an alternate set of operating instructions written into their protein-making machinery, which can quickly alter the proteins' contents, functions and ability to survive. The UMD study, published in Nature, is the first to demonstrate the phenomenon of programmed ribosomal frameshifting in a human gene. Frameshifting helps regulate the gene's immune response, the authors report.
National Institutes of Health, National Science Foundation

Contact: Abby Robinson
abbyr@umd.edu
301-405-5845
University of Maryland

Public Release: 9-Jul-2014
Ophthalmology
Depression in AMD patients with low vision can be halved by integrated therapies
The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration. The results of the study were published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.
NIH/National Eye Institute

Contact: Dayle Kern
dkern@aao.org
415-447-0375
American Academy of Ophthalmology

Showing releases 151-175 out of 3443.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.